We investigated the changes in body mass and parameters of both renal function and fluid metabolism in a case study in a female ultra-endurance runner during the longest multi-stage mountain ultramarathon in Europe, the 'Swiss Jura Marathon' in 2008. The female ultra-runner performed the 7 stages with a total distance of 175 km, a total ascent of 5,000 m, and a total descent of 8,000 m within 23:11 h: min, finishing as second female runner. By the end of the race, body mass decreased by 0.3 kg, fat mass by 1.2 kg and skeletal muscle mass by 0.7 kg. Haemoglobin and haematocrit decreased by 4.5% and 7.5 %, respectively, and plasma volume increased by 10 %. Serum osmolality decreased by 3.3%. Parameters of myocellular damage increased substantially (CK + 630 %, LDH + 178 % and GOT + 181 %). Creatinine continuously increased in plasma (+ 23 %) and urine (+ 47 %). Creatinine clearance (-18.7 %), glomerular filtration rate (-19.4 %) and serum albumin (-10.6 %) decreased. Urinary specific gravity decreased after each stage and was increased before each stage. Urinary osmolality decreased after each stage and was increased before each stage. The average daily fluid intake from stage 1 to stage 7 (during performance and rest) was 4.9 l per day. Total body water increased by 1.2 l by the end of the race. The potassium-to-sodium ratio in urine was increased after each stage. We assume that the increase in total body water was due to an increased activity in the renin-angiotensin-aldosterone-system as evidenced by the change in urinary electrolytes after the stages and an increased activity of vasopressin as evidenced by increase of urinary osmolality before the stages.
INTRODUCTION
Ultra-endurance races are of increasing popularity. Apart from the classic marathon run over 42.195 The decrease in skeletal muscle mass in long-distance running can be explained by the eccentric component in running (Fridén, 1984 Regarding these findings, the question is whether there is a link between skeletal muscle damage, impairment of renal function and retention, respectively, and accumulation in total body water.
As disorders in fluid and electrolyte metabolism are rather frequently found in female endurance athletes (Speedy, Faris, Hamlin et al., 1997; Speedy, Noakes, Rogers et al., 1999), we focused our investigation on a female ultra-runner. In a recent case study in a female ultraendurance runner in a multi-stage ultra-endurance run, a continuous accumulation of total body water has been found (Knechtle et al., 2008a).
The aim of the present case study was therefore to investigate whether skeletal muscle damage due to ultra-running could be responsible for the impairment of renal function, thus leading to continuous accumulation of total body water. We investigated a female ultra-runner during a multi-stage ultra-endurance mountain-marathon with high ascents and deep descents and focused on skeletal muscle damage and changes in total body water and fluid metabolism.
MATERIALS AND METHODS

Athlete and race
The female ultra-runner (43 years, 57 kg body mass, 1.72 m body height) has been running for four years and has performed 2 marathons with a personal best time of 4:50 h: min. She participated in 2008 in the 'Swiss Jura Marathon', a multi-stage ultra-endurance run over 7 stages with a total distance of 175 km, with a total ascent of 5,000 m and a total descent of 8,000 m. The study was approved by the Institutional Review Board for use of Human subjects of the Canton of St. Gallen, Switzerland. The athlete was informed of the experimental risks and gave informed written consent. The 18 th edition of the 'Swiss Jura Marathon' took place from 6 July to 12 July 2008. It is the longest mountain multi-stage ultraendurance run in Europe, held in the mountains of the 'Jura' from Geneva to Basel. Table 1 represents the stages of the run with the ascents and the descents. 
Measurements and calculations
Body mass, percent total body water and urinary parameters were determined before and after each stage. Venous blood samples and anthropometric measurements were performed before the start of the race and after stages 1, 3, 5 and 7. Skeletal muscle mass and percent body fat was calculated using anthropometric measurements. Percent total body water was determined using bioelectrical impedance analysis. Body mass was measured using the bioelectrical impedance analysis balance Tanita BC-545 (Tanita Corporation of America, Arlington Heights, IL, USA) to the nearest 0.1 kg. Skeletal muscle mass was calculated using the anthropometric method according to Lee, Wang, Heo, Ross, Janssen and Heymsfield (2000). Percentage of body fat was calculated using the anthropometric method following Ball, Swan and Desimone (2004). Percent total body water was measured using Tanita BC-545. Impedance measurements were performed with the athlete standing in an upright position, barefoot in running wear, on foot-electrodes on the platform of the instrument, with the legs and thighs apart, and the arms without contact to the torso. The runner stood on the 4 footelectrodes: 2 oval and 2 heel shaped electrodes, and gripped the 2 palm-and-thumb electrodes in order to yield 2 thumb and 2 palm electrodes. Since body weight and skeletal muscle mass are expressed in kg, fat mass was calculated in kg from body mass and percent body fat. Total body water was calculated from body weight and percent total body water. Venous blood samples were drawn after venipuncture of an antecubital vein, two Sarstedt S-Monovettes (serum gel, 7.5 ml) for chemical and one Sarstedt S-Monovette (lithium heparine, 2.7 ml) (Sarstedt, Nümbrecht, Germany) for haematological analysis were drawn. One Sarstedt monovette for urine (10 ml) was filled. Monovettes for serum were centrifuged at 3,000 g for 10 min at 4° C. Serum was collected and stored on ice. Blood and urinary samples were transported immediately after collection to the laboratory and analysed within 6 hours. In the venous blood samples, haemoglobin, haematocrit, creatinine, urea, sodium, potassium, plasma osmolality, creatine-kinase, lactic dehydrogenase (LDH), glutamate oxalacetate transaminase (GOT) and albumin were measured. In the urinary samples, creatinine, urea, sodium, potassium, urinary specific gravity and urinary osmolality were determined. Haemoglobin and haematocrit were determined using ADVIA ® 120 (Siemens Healthcare Diagnostics, Deerfield, IL, USA). In the serum samples, creatinine, urea, sodium, potassium, creatinekinase, LDH, GOT and albumin were measured using COBAS INTEGRA ® 800 (Roche, Germany). Osmolality of plasma and urine was determined using Fiske ® Modell 210 MikroOsmometer (IG Instrumenten-Gesellschaft AG, Zurich, Switzerland). Urinary specific gravity was analysed using Clinitek Atlas ® Automated Urine Chemistry Analyzer (Siemens Healthcare Diagnostics, Deerfield, IL, USA). Creatinine and urea were measured using COBAS INTEGRA ® 800. Electrolytes in the urinary samples were determined using ISE IL 943 Flame Photometer (GMI, Inc., Minnesota, USA). The change in plasma volume was calculated according to Dill and Costill (1974) . The creatinine clearance was calculated using the method of Cockroft and Gault (1976) and the glomerular filtration rate was calculated according to Levey, Bosch, Lewis, Greene, Rogers and Roth (1999). The runner recorded fluid intake during the stages and during rest.
RESULTS
The athlete finished the 175 km within 23:11 h: min as the second female runner. By the end of the race, body mass was decreased by 0.3 kg, fat mass by 1.2 kg and skeletal muscle mass by 0.7 kg (Figure 1 ). Haemoglobin and haematocrit were reduced by 4.5 % and 7.5 %, respectively, and plasma volume increased by 10 % by the end of the race (Figure 2 ). Serum osmolality decreased by 3.3 %. Parameters of myocellular damage increased substantially (CK + 630 %, LDH + 178 % und GOT +181 %) (Figure 3 ). Creatinine continuously increased in plasma (+ 23 %) ( Figure 4 ) and urine (+ 47 %) ( Figure 5 ). Both creatinine clearance (-18.7 %) and glomerular filtration rate (-19.4 %) decreased. Serum albumin decreased by 10.6 % (Figure 4) . Body mass and urinary specific gravity decreased after each stage and was increased before each stage ( Figure 6 ). Urinary osmolality decreased after each stage and was increased before each stage. The average daily fluid intake from stage 1 to stage 7 (during and after the stage) was 4.9 l per day ( Table 2 ). Total body water was increased by 1.2 l and the potassium-to-sodium ratio in urine was increased after each stage ( Figure 6 ). 
DISCUSSION
In this multi-stage ultra-endurance run, body mass, skeletal muscle mass and fat mass were reduced whereas total body water and plasma volume increased by the end of the race. The time course of body mass and urinary specific gravity indicates dehydration after each stage. The increase in urinary osmolality before each stage might be due to an increased activity of vasopressin (Fellmann et al., 1989 ) and the increased potassium-to-sodium ratio in urine after each stage reflects a contraction of the effective extra-cellular volume leading to a hyperreninemic hyperaldosteronemia. Immediately after a 24-hour run, plasma volume was initially reduced, but started to increase after the race with a peak on day 2 (Fellmann et al., 1989).
As Wade et al. (1981) have demonstrated in a multi-stage ultra-endurance run, aldosterone excretion was continuously elevated although plasma sodium was reduced by the end of the race. The potassium-to-sodium ratio in urine was < 1 pre-race, and increased after stages 1, 2 and 7 to > 1 but returned to < 1 after each stage ( Figure 6 ). We interpreted the decreases in urinary sodium as a reaction to the stimulation in the renin-angiotensin-aldosterone-system (RAAS). However, we were not able to measure RAAS which is a limitation of the study. The changes in urinary sodium and potassium suggest that more potassium than sodium was excreted during the performance, and the positive potassium-to-sodium ratio is suggestive for an increased aldosterone activity. The potassium-to-sodium ratio in urine > 1.0 reflects a contraction of the effective extra-cellular volume leading to a hyperreninemic hyperaldosteronemia. The potassium-to-sodium ratio in urine is a physiological reflexion of the potassium secretion in the distal tubulus and of sodium re-absorption an estimation of aldosterone activity in serum. The increase in urinary osmolality before each stage might indicate hypo-hydration, e.g. by relative fluid restriction or might be due to an increased activity of vasopressin (Fellmann et al., 1989 ).
The increase in total body water might also be explained by the endocrine situation in females. Our female runner was one week after her last period, therefore in the follicular phase and pre-ovulatory. In pre-ovulation, estrogen is elevated and with the start of the luteal phase, progesterone increases. The increase in progesterone is directly correlated with the increase in aldosterone which is also increased in the luteal phase (Szmuilowicz, Adler, Williams et al., 2006) and enhances absorption of sodium and chloride in the kidney. However, although the female hormones have an effect on water and electrolyte metabolism, the menstrual cycle shows no clear influence on fluid balance and concentration of electrolytes (Bisson, Dunster, O'Hare, Hampton and Penney, 1992). Since the competition was in her follicular phase and not in the luteal phase, progesterone was not increased and presumably the female hormones had no influence on fluid metabolism.
De-or hyper hydration during a multi-stage ultra-endurance run?
A decrease in body weight is thought to be a result of dehydration in marathon (Pastene et al., 1996; Whiting et al., 1984) During the past 20 years, many parameters have been developed to accurately assess hydration status in human subjects. Apart from a change in body weight, haematological and urinary parameters, bioelectrical impedance, skin-fold thickness, heart rate and blood pressure are among these indices (Kavouras, 2002; Shireffs, 2003) . Although there is no 'gold standard' for the correct assessment of hydration status, it appears that changes in body weight, along with urine osmolality, specific gravity of urine, conductivity and colour of urine are among the most widely used indices (Kavouras, 2002) . The current evidence and opinions tend to favour urine indices, as the most promising marker available (Shireffs, 2003) . Haematological measurements such as plasma osmolality, plasma sodium or haematocrit are not as sensitive in detecting mild hypo-hydration as selected urinary parameters are (Armstrong, Maresh, Castellani et al., 1994). Our athlete showed after each stage a decrease in body weight and increase in urinary specific gravity ( Figure 6 ). According to the proposal of Kavouras (2002) our athlete was dehydrated after each stage, but rehydrated before each subsequent stage. The present female athlete showed a continuous increase in plasma volume (Figure 2 ) during the race. Kaminsky and Paul (1991) found a significant relationship between fluid intake and change in plasma volume. Regarding the fluid intake of our athlete (Table 2) , an excessive fluid intake leading to overload (Speedy et al., 1997; Speedy et al., 1999) thus leading to plasma volume expansion, can be excluded. The decrease in serum osmolality ( Figure 2 ) and urinary osmolality after each stage in combination with the increase in total body water ( Figure 6 ) might indicate hypotonic hyperhydration. This might be due to fluid overload, impaired renal function, lack of protein and/or an increased activity in vasopressin. In contrast to our finding, Wade et al. (1981) found in a 20-day 500-km race an elevation in osmolality. Osmolality is a primary regulator of the release of vasopressin. When osmolality decreases, the secretion of vasopressin will be reduced and consequently plasma volume will be reduced. This leads to an activation of the RAAS with an increased activity in aldosterone and reabsorption in sodium so that water retention occurs. We would therefore presume that our athlete was hyperhydrated rather than dehydrated after the race.
We would not support the hypothesis of hypoproteinemic oedema. The decrease in albumin is most probably due to hemodilution as evidenced by the decrease in haemoglobin and haematocrit. This may also lead to the change in the other serum measures. Furthermore, we assume that renal function was not impaired. Unfortunately, the intake of pain killers such as NSAID was not asked. NSAID can also disrupt fluid balance.
CONCLUSIONS
In one female ultra-runner during a multi-stage mountain ultra-endurance run, a decrease in body mass, skeletal muscle mass and fat muss occurred by the end of the race. After each stage, body mass was decreased and urinary specific gravity increased, indicating dehydration. Before the next stage, body mass and urinary specific gravity was restored. In addition, an increase in total body water and plasma volume could be detected by the end of the race. We assume that the continuous increase in total body water was due to an increased activity in the RAAS as evidenced by the change in urinary electrolytes after the stages and an increased activity of vasopressin as evidenced by increase of urinary osmolality before the stages. For future studies, the activity of the hormones aldosterone and vasopressin should be determined in a larger sample of ultra-runners during a multi-stage ultra-endurance run.
